OCEA

Ocean Biomedical, Inc.

0.56 USD

Last updated Dec 11, 13:16 UTC

Yesterday HIGH

$0.62

Yesterday LOW

$0.56

52w HIGH

$26.6

52w LOW

$0.53

EPS

-0.49

PE

-1.14

Next Earnings

Dec 22, 2023

Overview News Government Trades

Ocean Biomedical, Inc. stock is down -65.21% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November.

Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in New York, New York.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Vandana Singh

Tue Aug 29, 2023

EXCLUSIVE: Ocean Biomedical Announces New Patent For Fibrosis Candidate Catering To One Of Leading Death Causes In US

Ocean Biomedical Inc (NASDAQ: OCEA) announced that the United States Patent and Trademark Office has issued a patent covering Ocean’s anti-Chitinase 1 small molecule candidate.
Benzinga Newsdesk

Tue Aug 29, 2023

EXCLUSIVE: Ocean Biomedical Tells Benzinga Co Announces New Patent For Anti-Fibrosis Discovery With Allowance In Alcoholic Liver Disease And Multiple Fibrotic Conditions
Chris Katje

Mon Aug 28, 2023

10 Short Squeeze Stocks To Watch: Getty Images, Blue Apron, T Stamp, Black Rifle Coffee And More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.
Vandana Singh

Thu Aug 10, 2023

EXCLUSIVE: Ocean Biomedical Unveils Comprehensive Updates On Its Cancer, Malaria, Fibrosis Programs

Ocean Biomedical Inc (NASDAQ: OCEA) shared an update on its broad range of programs in malaria, fibrosis, and multiple cancers. Oncology Program:
ryanfaloona@benzinga.com

Tue Aug 1, 2023

Market-Moving News for August 1st

AMSC: 145% | Shares Of American Superconductor Up 100% Premarket; A Report First Published On Arxiv.org On July 22 'The First Room-Temperature Ambient-Pressure Superconductor' Has Been Met With
Chris Katje

Tue Jul 18, 2023

10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.
Benzinga Newsdesk

Tue Jul 11, 2023

Ocean Biomedical Says Working On Multivalent mRNA-Based Malaria Vaccine With Potential To Target Several Stages In The Malaria Cycle

Additionally, the company has discovered a new therapeutic approach with the potential to launch a whole new class of anti-malarials.Multiple U.S. and global patents are held by Ocean Biomedical for both the vaccine and
Happy Mohamed

Tue Jun 27, 2023

'Malaria Makes A Comeback In Florida And Texas; Five Confirmed Cases Across The Two States Are The First Instances Of Local Spread In The United States In 20 Year' - Gizmodo

https://gizmodo.com/with-a-new-developer-framework-building-in-xr-is-easie-1850491958 Mosquito season is in full swing across the U.S., and this year’s annual boom of summertime blood suckers comes with some
Benzinga Newsdesk

Tue Jun 27, 2023

Ocean Biomedical Joins The Russell 2000 Index
Chris Katje

Mon Jun 26, 2023

10 Short Squeeze Stocks To Watch: Intuitive Machines, Wearable Devices, Ocean Biomedical, Big Lots And More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.